← Eichor
Condition: Demyelinating Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Demyelinating Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Foot Muscles Training in Sclerosis
NA · 1 location(s) · Inés Llamas-Ramos · NCT06665607A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06494228RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
NA · 1 location(s) · Centro de Reabilitacao do Norte · NCT05461898Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NA · 1 location(s) · University of Michigan · NCT07392879A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Skeletal Muscle Aging and Responsiveness in Aged People With MS
NA · 1 location(s) · Oklahoma Medical Research Foundation · NCT07500727Lorraine Registry of Multiple Sclerosis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT02883335Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · 39 location(s) · TG Therapeutics, Inc. · NCT07503873A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07313462Home Based Infusions for Ocrelizumab
Phase 4 · 1 location(s) · University of Colorado, Denver · NCT04650321Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Phase N/A · 3 location(s) · IRCCS San Camillo, Venezia, Italy · NCT05934188Krabbe Disease Global Patient Registry
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT02993796Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Phase 4 · 1 location(s) · Northwestern University · NCT07225361Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Phase N/A · 23 location(s) · argenx · NCT07264426Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07167680China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis
NA · 1 location(s) · Aristotle University Of Thessaloniki · NCT04806568Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
NA · 4 location(s) · Third Military Medical University · NCT06796920Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis
NA · 1 location(s) · Clinique Neuro-Outaouais · NCT07159789High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NA · 2 location(s) · Marquette University · NCT05735691Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT04819737Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
NA · 1 location(s) · University Hospital, Lille · NCT04573673Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1 · 1 location(s) · Tongji Hospital · NCT06620809Care in Multiple Sclerosis (MS)
Phase N/A · 6 location(s) · NYU Langone Health · NCT07011914T-cell Therapy in Patients With PML
Phase 2 · 6 location(s) · Hannover Medical School · NCT06990087Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Phase N/A · 2 location(s) · Istituto Auxologico Italiano · NCT06343558
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.